Rene Sindlev

Rene Sindlev, listed as board member, appears in our data through filings on Lunai Bioworks Inc. shares, published by SEC (Form 4). Over a trading history stretching from 16 February 2018 to 20 February 2024, the count stands at 22 filings.

No open-market sale appears; the market trades are 12 purchases worth €3.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants.

A typical purchase (the median) is worth €201k. Clusters matter here: 1 out of 11 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 22 February 2024: a share grant of €232k, in Lunai Bioworks Inc. The most recent open-market purchase was published on 20 May 2022, 1,633 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.